Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-012289
Filing Date
2025-05-07
Accepted
2025-05-07 20:45:11
Documents
1
Period of Report
2025-04-27

Document Format Files

Seq Description Document Type Size
1 form4-05072025_080507.html 4  
1 form4-05072025_080507.xml 4 15333
  Complete submission text file 0001415889-25-012289.txt   16928
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Issuer) CIK: 0001740279 (see all company filings)

EIN.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address IN8BIO, INC. EMPIRE STATE BUILDING, SUITE 5330 NEW YORK NY 10118
Business Address
Rochlin Kate (Reporting) CIK: 0001898521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39692 | Film No.: 25923431